Manufacturer
10 recalls in our database name Legacy Pharmaceutical Packaging LLC as the manufacturing or recalling firm.
Of the 10 recalls from Legacy Pharmaceutical Packaging LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 6 (60%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Legacy Pharmaceutical Packaging LLC is recalling 161,664 bottles of Sertraline Hydrochloride 100 mg tablets distributed in California and Arkansas due to inadequate line clearance during manufacturing that may result in product comingling.
Legacy Pharmaceutical Packaging LLC is recalling 111,948 bottles of Metformin Hydrochloride 1000 mg tablets because tablets with different imprints were found in the bottles.
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets 50 mg due to trace amounts of the impurity NMBA found in the active ingredient.
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets, 50 mg, because an impurity was detected. The recall covers 179,544 bottles distributed in Arizona, Indiana, and Tennessee.
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets, 50 mg, due to the presence of an impurity, N-Methylnitrosobutyric acid (NMBA).
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets, 100 mg, due to the presence of the impurity N-Methylnitrosobutyric acid (NMBA).
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets, 25 mg, because an impurity was detected. The recall involves 456,732 bottles distributed by Wal-Mart.
Legacy Pharmaceutical Packaging LLC is recalling 48,012 bottles of atenolol 50 mg tablets because a customer reported finding a paroxetine 20 mg tablet inside a bottle.
Legacy Pharmaceutical Packaging LLC is recalling 1,644 bottles of Lorazepam 0.5 mg tablets because of incorrect or missing lot and expiration dates.
Legacy Pharmaceutical Packaging is recalling Walmart Amlodipine Besylate Tablets 10 mg due to a label error listing 5 mg in the USP description.